Replacement therapy for invasive procedures in patients with haemophilia: Literature review, European survey and recommendations

Haemophilia

Volumn 15, Issue 3, 2009, Pages 639-658

  Hermans, Cedric ^a   Altisent, C ^b   Batorova, A ^c   Chambost, H ^d   De Moerloose, P ^e   Karafoulidou, A ^f   Klamroth, R ^g   Richards, M ^h   White, B ⁱ   Dolan, G ^j  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^c UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

^d TIMONE HOSPITAL   (France)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^f LAIKO GENERAL HOSPITAL   (Greece)

^g Vivantes Klinikum im Friedrichhain Klinik fuer Innere Medizin   (Germany)

^h ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

ⁱ ST JAMES S HOSPITAL   (Ireland)

^j QUEEN S MEDICAL CENTRE   (United Kingdom)

more..

Author keywords

Haemophilia; Invasive procedures; Recommendations; Replacement therapy; Survey

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; FIBRIN GLUE; LOW MOLECULAR WEIGHT HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ADJUVANT THERAPY; BLOOD GROUP; CATHETERIZATION; CIRCUMCISION; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DOSE INCREASE; EUROPE; HEALTH SURVEY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; INVASIVE PROCEDURE; LIVER BIOPSY; MEDICAL LITERATURE; ORTHOPEDIC SURGERY; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; REVIEW; SUBSTITUTION THERAPY; SYNOVECTOMY; THROMBOSIS; TONSILLECTOMY; TOOTH EXTRACTION;

DEVICE REMOVAL; HEALTH CARE SURVEYS; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS, SURGICAL; HEMOSTATICS; HUMANS; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINES AS TOPIC;

EID: 65449144703     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01950.x     Document Type: Review

References (119)

1. Gringeri A. Treatment protocol of haemophilia and other congenital bleeding disorders in Italy. Italian Association of Hemophilia Centers (AICE). Haemophilia 1998; 4: 423-4.
2. United Kingdom Haemophilia Centre Doctors'Organisation. Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. Haemophilia 2003; 9: 1-23.
3. Santagostino E, Mannucci PM, Bianchi BA. Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy. Haemophilia 2000; 6: 1-10.
4. Berntorp E. Guidelines on treatment of haemophilia in Sweden. Haemophilia 1998; 4: 425-6.
5. Mauser-Bunschoten EP, Roosendaal G, Van Den Berg HM. Treatment protocols in The Netherlands. Haemophilia 1998; 4: 428-30.
6. Mauser-Bunschoten EP, Roosendaal G, Van Den Berg HM. Product choice and haemophilia treatment in the Netherlands. Haemophilia 2001; 7: 96-8.
7. Konsensus Empfehlungen zur Hämophilie. Behandlung in Deutschland, Hämophilie-Blätter 2/2000, 'Gesamtstrategie Blutversorgung angesichts vCJK'. Bericht der Arbeitsgruppe Paul-Ehrlich-Institut/Robert Koch-Institut, 2001.
8. Teitel JM. National haemophilia treatment protocols: Canada. Haemophilia 1998; 4: 422-3.
9. Srivastava A. Dose and response in haemophilia - optimization of factor replacement therapy. Br J Haematol 2004; 127: 12-25.
10. Nilsson IM, Hedner U, Ahlberg A, Larsson SA, Bergentz SE. Surgery of hemophiliacs - 20 years' experience. World J Surg 1977; 1: 55-66.
11. Krieger JN, Hilgartner MW, Redo SF. Surgery in patients with congenital disorders of blood coagulation. Ann Surg 1977; 185: 290-4.
12. Rudowski WJ. Moynihan Lecture, 1980. Major surgery in haemophilia. Ann R Coll Surg Engl 1981; 63: 111-7.
13. Willert HG, Horrig C, Ewald W, Scharrer I. Orthopaedic surgery in hemophilic patients. Arch Orthop Trauma Surg 1983; 101: 121-32.
14. Kasper CK, Boylen AL, Ewing NP, Luck JV Jr, Dietrich SL. Hematologic management of hemophilia A for surgery. JAMA 1985; 253: 1279-83.
15. Brown B, Steed DL, Webster MW et al. General surgery in adult hemophiliacs. Surgery 1986; 99: 154-9.
16. Kitchens CS. Surgery in hemophilia and related disorders. A prospective study of 100 consecutive procedures. Medicine (Baltimore) 1986; 65: 34-45.
17. Martinowitz U, Schulman S, Gitel S, Horozowski H, Heim M, Varon D. Adjusted dose continuous infusion of factor VIII in patients with haemophilia A. Br J Haematol 1992; 82: 729-34.
18. Schulman S, Varon D, Keller N, Gitel S, Martinowitz U. Monoclonal purified F VIII for continuous infusion: Stability, microbiological safety and clinical experience. Thromb Haemost 1994; 72: 403-7.
19. Bhushan V, Chandy M, Khanduri U, Dennison D, Srivastava A, Apte S. Surgery in patients with congenital coagulation disorders. Natl Med J India 1994; 7: 8-12.
20. Lofqvist T, Nilsson IM, Petersson C. Orthopaedic surgery in hemophilia. 20 Years'experience in Sweden. Clin Orthop Relat Res 1996; 00: 232-41.
21. Hay CR, Doughty HI, Savidge GF. Continuous infusion of factor VIII for surgery and major bleeding. Blood Coagul Fibrinolysis 1996; 7(Suppl. 1): S15-9.
22. Shapiro AD, Ragni MV, Lusher JM et al. Safety and efficacy of monoclonal antibody purified factor IX concentrate in previously untreated patients with hemophilia B. Thromb Haemost 1996; 75: 30-5.
23. White GC, Courter S, Bray GL, Lee M, Gomperts ED. A multicenter study of recombinant factor VIII (Recombinate) in previously treated patients with hemophilia A. The Recombinate Previously Treated Patient Study Group. Thromb Haemost 1997; 77: 660-7.
24. Srivastava A, Chandy M, Sunderaj GD et al. Low-dose intermittent factor replacement for post-operative haemostasis in haemophilia. Haemophilia 1998; 4: 799-801.
25. Heeg M, Meyer K, Smid WM, Van H Jr, Van der MJ. Total knee and hip arthroplasty in haemophilic patients. Haemophilia 1998; 4: 747-51.
26. Campbell PJ, Rickard KA. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: A single centre Australian experience. Aust N Z J Med 1998; 28: 440-5.
27. Ghosh K, Jijina F, Pathare AV, Mohanty D. Surgery in haemophilia: experience from a centre in India. Haemophilia 1998; 4: 94-7.
28. Negrier C, Menart C, Attali O et al. Evaluation of coagulation equilibrium at baseline and during factor VIII and factor IX replacement in haemophiliacs. Blood Coagul Fibrinolysis 1998; 9(Suppl. 1): S135-41.
29. Tagariello G, Davoli PG, Gajo GB et al. Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion. Haemophilia 1999; 5: 426-30.
30. Rochat C, McFadyen ML, Schwyzer R, Gillham A, Cruickshank A. Continuous infusion of intermediate-purity factor VIII in haemophilia A patients undergoing elective surgery. Haemophilia 1999; 5: 181-6.
31. Scharrer I, Brackmann HH, Sultan Y et al. Efficacy of a sucrose-formulated recombinant factor VIII used for 22 surgical procedures in patients with severe haemophilia A. Haemophilia 2000; 6: 614-8.
32. Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000; 110: 715-20.
33. Bastounis E, Pikoulis E, Leppaniemi A, Alexiou D, Tsigris C, Tsetis A. General surgery in haemophiliac patients. Postgrad Med J 2000; 76: 494-5.
34. Chowdary P, Dasani H, Jones JA et al. Recombinant factor IX (BeneFix) by adjusted continuous infusion: A study of stability, sterility and clinical experience. Haemophilia 2001; 7: 140-5.
35. Scharrer I. Experience with KOGENATE Bayer in surgical procedures. Haemophilia 2002; 8(Suppl. 2): 15-8.
36. Mishra V, Tjonnfjord GE, Paus AC, Vaaler S. Orthopaedic surgery in severe bleeding disorders: A low-volume, high-cost procedure. Haemophilia 2002; 8: 809-14.
37. Ragni MV, Pasi KJ, White GC, Giangrande PL, Courter SG, Tubridy KL. Use of recombinant factor IX in subjects with haemophilia B undergoing surgery. Haemophilia 2002; 8: 91-7.
38. Dingli D, Gastineau DA, Gilchrist GS, Nichols WL, Wilke JL. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates. Haemophilia 2002; 8: 629-34.
39. Hoots WK, Leissinger C, Stabler S et al. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B. Haemophilia 2003; 9: 164-72.
40. Evans G, Collett M, Came N, Lloyd J, Powell L, Street A. MonoFIX-VF, a new mono-component factor IX concentrate: A single-centre continuous-infusion study. Haemophilia 2002; 8: 635-8.
41. Lusher JM, Lee CA, Kessler CM, Bedrosian CL. The safety and efficacy of B-domain deleted recombinant factor VIII concentrate in patients with severe haemophilia A. Haemophilia 2003; 9: 38-49.
42. Wolf DM, Rokicka-Milewska R, Lopaciuk S et al. Clinical efficacy, safety and pharmacokinetic properties of the factor VIII concentrate Haemoctin SDH in previously treated patients with severe haemophilia A. Haemophilia 2004; 10: 438-48.
43. Stieltjes N, Altisent C, Auerswald G et al. Continuous infusion of B-domain deleted recombinant factor VIII (ReFacto) in patients with haemophilia A undergoing surgery: Clinical experience. Haemophilia 2004; 10: 452-8.
44. Lee V, Srivastava A, PalaniKumar C et al. External fixators in haemophilia. Haemophilia 2004; 10: 52-7.
45. Fernandez-Palazzi F, Rivas S, Viso R, de Bosch NB, de Saez AR, Boadas A. Synovectomy with rifampicin in haemophilic haemarthrosis. Haemophilia 2000; 6: 562-5.
46. Mathew P, Talbut DC, Frogameni A et al. Isotopic synovectomy with P-32 in paediatric patients with haemophilia. Haemophilia 2000; 6: 547-55.
47. Silva M, Luck JV Jr, Siegel ME. 32P chromic phosphate radiosynovectomy for chronic haemophilic synovitis. Haemophilia 2001; 7(Suppl. 2): 40-9.
48. Chew EM, Tien SL, Sundram FX, Ho YK, Howe TS. Radionuclide synovectomy and chronic haemophilic synovitis in Asians: A retrospective study. Haemophilia 2003; 9: 632-7.
49. Lesesne HR, Morgan JE, Blatt PM, Webster WP, Roberts HR. Liver biopsy in hemophilia A. Ann Intern Med 1977; 86: 703-7.
50. Preston FE, Triger DR, Underwood JC et al. Percutaneous liver biopsy and chronic liver disease in haemophiliacs. Lancet 1978; 2: 592-4.
51. White GC, Zeitler KD, Lesesne HR et al. Chronic hepatitis in patients with hemophilia A: Histologic studies in patients with intermittently abnormal liver function tests. Blood 1982; 60: 1259-62.
52. Aledort LM, Levine PH, Hilgartner M et al. A study of liver biopsies and liver disease among hemophiliacs. Blood 1985; 66: 367-72.
53. Hay CR, Preston FE, Triger DR, Greaves M, Underwood JC, Westlake L. Predictive markers of chronic liver disease in hemophilia. Blood 1987; 69: 1595-9.
54. Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI. A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 1991; 78: 1672-7.
55. Ahmed MM, Mutimer DJ, Elias E et al. A combined management protocol for patients with coagulation disorders infected with hepatitis C virus. Br J Haematol 1996; 95: 383-8.
56. Hanley JP, Jarvis LM, Andrews J et al. Investigation of chronic hepatitis C infection in individuals with haemophilia: Assessment of invasive and non-invasive methods. Br J Haematol 1996; 94: 159-65.
57. Wong VS, Baglin T, Beacham E, Wight DD, Petrik J, Alexander GJ. The role for liver biopsy in haemophiliacs infected with the hepatitis C virus. Br J Haematol 1997; 97: 343-7.
58. Gupta R, Druy EM, Kessler CM. Safety and potential usefulness of liver biopsy in HIV-seropositive haemophiliacs employing a transjugular venous approach. Haemophilia 1997; 3: 201-4.
59. Fukuda Y, Nakano I, Katano Y et al. Assessment and treatment of liver disease in Japanese haemophilia patients. Haemophilia 1998; 4: 595-600.
60. Adamowicz-Salach A, Pawelec K, Loch T et al. Incidence and treatment of hepatitis C virus infection in children with haemophilia in Poland. Haemophilia 1999; 5: 436-40.
61. Farrell RJ, Smiddy PF, Pilkington RM et al. Guided versus blind liver biopsy for chronic hepatitis C: Clinical benefits and costs. J Hepatol 1999; 30: 580-7.
62. McMahon C, Pilkington R, Shea EO, Kelleher D, Smith OP. Liver biopsy in Irish hepatitis C-infected patients with inherited bleeding disorders. Br J Haematol 2000; 109: 354-9.
63. Venkataramani A, Behling C, Rond R, Glass C, Lyche K. Liver biopsies in adult hemophiliacs with hepatitis C: A United States center's experience. Am J Gastroenterol 2000; 95: 2374-6.
64. Shields PL, Mutimer DJ, Muir D et al. Combined alpha interferon and ribavirin for the treatment of hepatitis C in patients with hereditary bleeding disorders. Br J Haematol 2000; 108: 254-8.
65. Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease. Br J Haematol 2001; 113: 87-93.
66. Delladetsima J, Katsarou O, Touloumi G, Vgenopoulou S, Hatzakis A, Karafoulidou A. Significance of immune status, genotype and viral load in the severity of chronic hepatitis C in HIV infected haemophilia patients. Haemophilia 2002; 8: 668-73.
67. Denzer U, Helmreich-Becker I, Galle PR, Lohse AW. Liver assessment and biopsy in patients with marked coagulopathy: Value of mini-laparoscopy and control of bleeding. Am J Gastroenterol 2003; 98: 893-900.
68. DiMichele DM, Mirani G, Wilfredo CP, Trost DW, Talal AH. Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders and hepatitis C infection. Haemophilia 2003; 9: 613-8.
69. Stieltjes N, Ounnoughene N, Sava E et al. Interest of transjugular liver biopsy in adult patients with haemophilia or other congenital bleeding disorders infected with hepatitis C virus. Br J Haematol 2004; 125: 769-76.
70. Saab S, Cho D, Quon DV et al. Same day outpatient transjugular liver biopsies in haemophilia. Haemophilia 2004; 10: 727-31.
71. Shin JL, Teitel J, Swain MG et.al. A Canadian multicenter retrospective study evaluating transjugular liver biopsy in patients with congenital bleeding disorders and hepatitis C: Is it safe and useful? Am J Hematol 2005; 78: 85-93.
72. Dawson MA, McCarthy PH, Walsh ME et al. Transjugular liver biopsy is a safe and effective intervention to guide management for patients with a congenital bleeding disorder infected with hepatitis C. Intern Med J 2005; 35: 556-9.
73. Detrait M, Pothen D, Brenard R, Starkel P, Hermans C. Feasibility, safety and cost-effectiveness of transjugular liver biopsy following major surgery in patients with haemophilia. Haemophilia 2007; 13: 588-92.
74. Sterling RK, Lyons CD, Stravitz RT et al. Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: Safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease. Haemophilia 2007; 13: 164-71.
75. Thach T, Gazengel C, Francois M, Torchet MF, Dautzenberg MD, Roulleau P. [Adenoidectomy and tonsillectomy in children with hemophilia and von Willebrand disease]. Ann Otolaryngol Chir Cervicofac 1985; 102: 449-56.
76. Prinsley P, Wood M, Lee CA. Adenotonsillectomy in patients with inherited bleeding disorders. Clin Otolaryngol Allied Sci 1993; 18: 206-8.
77. Conlon B, Daly N, Temperely I, McShane D. ENT surgery in children with inherited bleeding disorders. J Laryngol Otol 1996; 110: 947-9.
78. Martinowitz U, Varon D, Jonas P et al. Circumcision in hemophilia: The use of fibrin glue for local hemostasis. J Urol 1992; 148: 855-7.
79. Kavakli K, Nisli G, Ozcan C et al. Safer and much cheaper circumcision using fibrin glue in severe haemophilia. Haemophilia 1997; 3: 209-11.
80. Avanoglu A, Celik A, Ulman I et al. Safer circumcision in patients with haemophilia: The use of fibrin glue for local haemostasis. BJU Int 1999; 83: 91-4.
81. Shittu OB, Shokunbi WA. Circumcision in haemophiliacs: The Nigerian experience. Haemophilia 2001; 7: 534-6.
82. Zulfikar B, Karaman MI, Ovali F. Circumcision in hemophilia. An overview. Haemophilia 2003; 30: 1-6.
83. Karaman MI, Zulfikar B, Caskurlu T, Ergenekon E. Circumcision in hemophilia: A cost-effective method using a novel device. J Pediatr Surg 2004; 39: 1562-4.
84. Ljung R, Petrini P, Lindgren AK, Berntorp E. Implantable central venous catheter facilitates prophylactic treatment in children with haemophilia. Acta Paediatr 1992; 81: 918-20.
85. Girvan DP, deVeber LL, Inwood MJ, Clegg EA. Subcutaneous infusion ports in the pediatric patient with hemophilia. J Pediatr Surg 1994; 29: 1220-3.
86. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
87. Blanchette VS, Al-Musa A, Stain AM, Filler RM, Ingram J. Central venous access catheters in children with haemophilia. Blood Coagul Fibrinolysis 1996; 7(Suppl. 1): S39-44.
88. Smith OP, Hann IM. rVIIa therapy to secure haemostasis during central line insertion in children with high-responding FVIII inhibitors. Br J Haematol 1996; 92: 1002-4.
89. Perkins JL, Johnson VA, Osip JM et al. The use of implantable venous access devices (IVADs) in children with hemophilia. J Pediatr Hematol Oncol 1997; 19: 339-44.
90. Warrier I, Baird-Cox K, Lusher J. Use of central venous catheters in children with haemophilia: One haemophilia treatment centre experience. Haemophilia 1997; 3: 194-8.
91. Santagostino E, Gringeri A, Muca-Perja M, Mannucci PM. A prospective clinical trial of implantable central venous access in children with haemophilia. Br J Haematol 1998; 102: 1224-8.
92. Miller K, Buchanan GR, Zappa S et al. Implantable venous access devices in children with hemophilia: A report of low infection rates. J Pediatr 1998; 132: 934-8.
93. Van Den Berg HM, Fischer K, Roosendaal G, Mauser-Bunschoten EP. The use of the Port-A-Cath in children with haemophilia - a review. Haemophilia 1998; 4: 418-20.
94. Montoro JB, Altisent C, Pico M, Cabanas MJ, Vila M, Puig LL. Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor. Haemophilia 1998; 4: 762-5.
95. Bollard CM, Teague LR, Berry EW, Ockelford PA. The use of central venous catheters (portacaths) in children with haemophilia. Haemophilia 2000; 6: 66-70.
96. McMahon C, Smith J, Khair K, Liesner R, Hann IM, Smith OP. Central venous access devices in children with congenital coagulation disorders: complications and long-term outcome. Br J Haematol 2000; 110: 461-8.
97. Morado M, Jimenez-Yuste V, Villar A et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia 2001; 7: 551-6.
98. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 2004; 10: 134-46.
99. Biggs R, Rush BM, MacFarlane RG, Matthews JM, Johnstone FC, Hayton-Williams DS. Further experience in use of human antihaemophilic globulin (H.A.H.G.) for the control of bleeding after dental extraction in haemophilic patients: A report of the Medical Research Council's working party on human antihaemophilic globulin. Lancet 1965; 17: 969-74.
100. Tavenner RW. Epsilon-aminocaproic acid in the treatment of haemophilia and Christmas disease with special reference to the extraction of teeth. Br Dent J 1968; 124: 19-22.
101. Walsh PN, Rizza CR, Matthews JM et al. Epsilon-Aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: A double blind controlled trial. Br J Haematol 1971; 20: 463-75.
102. Forbes CD, Barr RD, Reid G et al. Tranexamic acid in control of haemorrhage after dental extraction in haemophilia and Christmas disease. Br Med J 1972; 2: 311-3.
103. Tavenner RW. Use of tranexamic acid in control of haemorrhage after extraction of teeth in haemophilia and Christmas disease. Br Med J 1972; 2: 314-5.
104. Ramstrom G, Blomback M. Tooth extractions in hemophiliacs. Int J Oral Surg 1975; 4: 1-17.
105. Kaneda T, Shikimori M, Watanabe I et al. The importance of local hemostatic procedures in dental extractions and oral mucosal bleeding of hemophiliac patients. Int J Oral Surg 1981; 10: 266-71.
106. Suzuki H, Takeuchi M, Sumi Y, Matsuda M, Shikimori M, Kaneda T. Local haemostasis for oral bleeding in patients with coagulopathy. Lancet 1983; 2: 1362-3.
107. Steinberg SE, Levin J, Bell WR. Evidence that less replacement therapy is required for dental extractions in hemophiliacs. Am J Hematol 1984; 16: 1-13.
108. Baudo F, de CF, Gatti R, Landonio G, Muti G, Scolari G. Local hemostasis after tooth extraction in patients with abnormal hemostatic function. Use of human fibrinogen concentrate. Haemostasis 1985; 15: 402-4.
109. Stajcic Z. The combined local/systemic use of antifibrinolytics in hemophiliacs undergoing dental extractions. Int J Oral Surg 1985; 14: 339-45.
110. Sindet-Pedersen S, Stenbjerg S. Effect of local antifibrinolytic treatment with tranexamic acid in hemophiliacs undergoing oral surgery. J Oral Maxillofac Surg 1986; 44: 703-7.
111. Baudo F, deCataldo F, Landonio G, Muti G. Management of oral bleeding in haemophilic patients. Lancet 1988; 2: 1082.
112. Ramstrom G, Blomback M, Egberg N, Johnsson H, Ljungberg B, Schulman S. Oral surgery in patients with hereditary bleeding disorders. A survey of treatment in the Stockholm area (1974-1985). Int J Oral Maxillofac Surg 1989; 18: 320-2.
113. Rakocz M, Mazar A, Varon D, Spierer S, Blinder D, Martinowitz U. Dental extractions in patients with bleeding disorders. The use of fibrin glue. Oral Surg Oral Med Oral Pathol 1993; 75: 280-2.
114. Waly NG. Local antifibrinolytic treatment with tranexamic acid in hemophilic children undergoing dental extractions. Egypt Dent J 1995; 41: 961-8.
115. Zanon E, Martinelli F, Bacci C, Zerbinati P, Girolami A. Proposal of a standard approach to dental extraction in haemophilia patients. A case-control study with good results. Haemophilia 2000; 6: 533-6.
116. Piot B, Sigaud-Fiks M, Huet P, Fressinaud E, Trossaert M, Mercier J. Management of dental extractions in patients with bleeding disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 247-50.
117. Frachon X, Pommereuil M, Berthier AM et al. Management options for dental extraction in hemophiliacs: A study of 55 extractions (2000-2002). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 270-5.
118. Franchini M, Rossetti G, Tagliaferri A et al. Dental procedures in adult patients with hereditary bleeding disorders: 10 years experience in three Italian Hemophilia Centers. Haemophilia 2005; 11: 504-9.
119. Correa ME, nnicchino-Bizzacchi JM, Jorge J Jr et al. Clinical impact of oral health indexes in dental extraction of hemophilic patients. J Oral Maxillofac Surg 2006; 64: 785-8.